Biliary Tract Cancer: Molecular Biology of Precursor Lesions

被引:2
|
作者
Manzano-Nunez, Fatima [1 ]
Aguilar, Lara Prates Tiago [1 ]
Sempoux, Christine [2 ]
Lemaigre, Frederic P. [1 ]
机构
[1] Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75-B1-7503, B-1200 Brussels, Belgium
[2] Univ Lausanne, Lausanne Univ Hosp CHUV, Inst Pathol, Lausanne, Switzerland
关键词
cholangiocarcinoma; gallbladder cancer; tumor progression; animal model; organoid; INTRADUCTAL PAPILLARY NEOPLASMS; GALLBLADDER CARCINOMA; PRENEOPLASTIC LESIONS; IMMUNOHISTOCHEMICAL ANALYSIS; INTRAEPITHELIAL NEOPLASIA; KRAS ACTIVATION; BETA-CATENIN; BILE-DUCTS; MUTATIONS; PROGRESSION;
D O I
10.1055/a-2207-9834
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Biliary tract cancer is a devastating malignancy of the bile ducts and gallbladder with a dismal prognosis. The study of precancerous lesions has received considerable attention and led to a histopathological classification which, in some respects, remains an evolving field. Consequently, increasing efforts have been devoted to characterizing the molecular pathogenesis of the precursor lesions, with the aim of better understanding the mechanisms of tumor progression, and with the ultimate goal of meeting the challenges of early diagnosis and treatment. This review delves into the molecular mechanisms that initiate and promote the development of precursor lesions of intraand extrahepatic cholangiocarcinoma and of gallbladder carcinoma. It addresses the genomic, epigenomic, and transcriptomic landscape of these precursors and provides an overview of animal and organoid models used to study them. In conclusion, this review summarizes the known molecular features of precancerous lesions in biliary tract cancer and highlights our fragmentary knowledge of the molecular pathogenesis of tumor initiation.
引用
收藏
页码:472 / 484
页数:13
相关论文
共 50 条
  • [31] Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
    Malenica, Ines
    Donadon, Matteo
    Lleo, Ana
    CANCERS, 2020, 12 (08) : 1 - 19
  • [32] Molecular pathology of biliary tract cancers
    Fava, Giammarco
    Marzioni, Marco
    Benedetti, Antonio
    Glaser, Shannon
    DeMorrow, Sharon
    Francis, Heather
    Alpini, Gianfranco
    CANCER LETTERS, 2007, 250 (02) : 155 - 167
  • [33] Precursor Lesions of Pancreatic Cancer
    Kim, Joo Y.
    Hong, Seung-Mo
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (10) : 603 - 610
  • [34] Angiogenesis in biliary tract cancer: targeting and therapeutic potential
    Rimini, Margherita
    Casadei-Gardini, Andrea
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (04) : 411 - 418
  • [35] Optimum chemotherapy for the management of advanced biliary tract cancer
    Ghosn, Marwan
    Kourie, Hampig Raphael
    El Rassy, Elie
    Chebib, Ralph
    El Karak, Fadi
    Hanna, Colette
    Nasr, Dolly
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (14) : 4121 - 4125
  • [36] Essential updates to the surgical treatment of biliary tract cancer
    Matsukuma, Satoshi
    Tokumitsu, Yukio
    Shindo, Yoshitaro
    Matsui, Hiroto
    Nagano, Hiroaki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2019, 3 (04): : 378 - 389
  • [37] Molecular biology of pancreatic cancer
    Zavoral, Miroslav
    Minarikova, Petra
    Zavada, Filip
    Salek, Cyril
    Minarik, Marek
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (24) : 2897 - 2908
  • [38] Biliary tract cancer: current challenges and future prospects
    Ghidini, Michele
    Pizzo, Claudio
    Botticelli, Andrea
    Hahne, Jens Claus
    Passalacqua, Rodolfo
    Tomasello, Gianluca
    Petrelli, Fausto
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 379 - 388
  • [39] Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer
    Tsavaris, N
    Kosmas, C
    Gouveris, P
    Gennatas, K
    Polyzos, A
    Mouratidou, D
    Tsipras, H
    Margaris, H
    Papastratis, G
    Tzima, E
    Papadoniou, N
    Karatzas, G
    Papalambros, E
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (02) : 193 - 198
  • [40] New Treatment Options for Advanced Biliary Tract Cancer
    Jonathan D. Mizrahi
    Rachna T. Shroff
    Current Treatment Options in Oncology, 2020, 21